These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8731103)

  • 1. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Kidney Int; 1996 May; 49(5):1379-85. PubMed ID: 8731103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    J Am Soc Nephrol; 1996 May; 7(5):728-36. PubMed ID: 8738808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Am J Kidney Dis; 1996 Jul; 28(1):53-61. PubMed ID: 8712222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and risk factors of ischemic heart disease in chronic uremia.
    Parfrey PS; Foley RN; Harnett JD; Kent GM; Murray D; Barre PE
    Kidney Int; 1996 May; 49(5):1428-34. PubMed ID: 8731110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic importance of left ventricular geometry in uremic cardiomyopathy.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barré PE
    J Am Soc Nephrol; 1995 Jun; 5(12):2024-31. PubMed ID: 7579050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocalcemia, morbidity, and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Hu L; O'Dea R; Murray DC; Barre PE
    Am J Nephrol; 1996; 16(5):386-93. PubMed ID: 8886175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy.
    Foley RN; Parfrey PS; Morgan J; Barré PE; Campbell P; Cartier P; Coyle D; Fine A; Handa P; Kingma I; Lau CY; Levin A; Mendelssohn D; Muirhead N; Murphy B; Plante RK; Posen G; Wells GA
    Kidney Int; 2000 Sep; 58(3):1325-35. PubMed ID: 10972697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac function and hematocrit level.
    Harnett JD; Kent GM; Foley RN; Parfrey PS
    Am J Kidney Dis; 1995 Apr; 25(4 Suppl 1):S3-7. PubMed ID: 7702071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renal transplantation on uremic cardiomyopathy.
    Parfrey PS; Harnett JD; Foley RN; Kent GM; Murray DC; Barre PE; Guttmann RD
    Transplantation; 1995 Nov; 60(9):908-14. PubMed ID: 7491692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and risk factors for left ventricular disorders in chronic uraemia.
    Parfrey PS; Foley RN; Harnett JD; Kent GM; Murray DC; Barre PE
    Nephrol Dial Transplant; 1996 Jul; 11(7):1277-85. PubMed ID: 8672023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Martin CJ; Murray DC; Barre PE
    Kidney Int; 1995 Jan; 47(1):186-92. PubMed ID: 7731145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic manifestations in end-stage renal disease.
    Ito T; Akamatsu K
    Heart Fail Rev; 2024 Mar; 29(2):465-478. PubMed ID: 38071738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.
    Klassen PS; Lowrie EG; Reddan DN; DeLong ER; Coladonato JA; Szczech LA; Lazarus JM; Owen WF
    JAMA; 2002 Mar; 287(12):1548-55. PubMed ID: 11911757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis.
    Hüting J
    Chest; 1994 Feb; 105(2):383-8. PubMed ID: 8306733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease.
    Foley RN; Parfrey PS; Kent GM; Harnett JD; Murray DC; Barre PE
    J Am Soc Nephrol; 2000 May; 11(5):912-916. PubMed ID: 10770969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
    BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.